Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.52
(1.07%)
HKD 8.52
(1.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.43 Billion HKD | 4.95% |
| 2022 | 4.22 Billion HKD | 10.18% |
| 2021 | 3.83 Billion HKD | 12.23% |
| 2020 | 3.41 Billion HKD | 8.88% |
| 2019 | 3.13 Billion HKD | -1.03% |
| 2018 | 3.17 Billion HKD | 14.87% |
| 2017 | 2.76 Billion HKD | 17.23% |
| 2016 | 2.35 Billion HKD | 16.17% |
| 2015 | 2.02 Billion HKD | 24.16% |
| 2014 | 1.63 Billion HKD | 15.77% |
| 2013 | 1.41 Billion HKD | 110.82% |
| 2012 | 668.85 Million HKD | 39.51% |
| 2011 | 479.44 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.27 Billion HKD | 0.0% |
| 2024 Q1 | 4.27 Billion HKD | -3.53% |
| 2023 Q2 | 4.1 Billion HKD | 0.0% |
| 2023 FY | 4.43 Billion HKD | 4.95% |
| 2023 Q1 | 4.1 Billion HKD | -2.82% |
| 2023 Q4 | 4.43 Billion HKD | 0.0% |
| 2023 Q3 | 4.43 Billion HKD | 7.99% |
| 2022 Q1 | 3.83 Billion HKD | -0.03% |
| 2022 FY | 4.22 Billion HKD | 10.18% |
| 2022 Q4 | 4.22 Billion HKD | 0.0% |
| 2022 Q3 | 4.22 Billion HKD | 10.22% |
| 2022 Q2 | 3.83 Billion HKD | 0.0% |
| 2021 Q1 | 3.51 Billion HKD | 2.81% |
| 2021 FY | 3.83 Billion HKD | 12.23% |
| 2021 Q3 | 3.83 Billion HKD | 9.17% |
| 2021 Q4 | 3.83 Billion HKD | 0.0% |
| 2021 Q2 | 3.51 Billion HKD | 0.0% |
| 2020 Q3 | 3.41 Billion HKD | 7.9% |
| 2020 FY | 3.41 Billion HKD | 8.88% |
| 2020 Q1 | 3.16 Billion HKD | 0.9% |
| 2020 Q2 | 3.16 Billion HKD | 0.0% |
| 2020 Q4 | 3.41 Billion HKD | 0.0% |
| 2019 Q4 | 3.13 Billion HKD | 0.0% |
| 2019 Q2 | 3.5 Billion HKD | 0.0% |
| 2019 FY | 3.13 Billion HKD | -1.03% |
| 2019 Q3 | 3.13 Billion HKD | -10.53% |
| 2019 Q1 | 3.5 Billion HKD | 10.62% |
| 2018 FY | 3.17 Billion HKD | 14.87% |
| 2018 Q4 | 3.17 Billion HKD | 0.0% |
| 2018 Q3 | 3.17 Billion HKD | 6.98% |
| 2018 Q2 | 2.96 Billion HKD | 0.0% |
| 2018 Q1 | - HKD | -100.0% |
| 2017 Q2 | 2.57 Billion HKD | 0.0% |
| 2017 FY | 2.76 Billion HKD | 17.23% |
| 2017 Q4 | 2.76 Billion HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 Q3 | - HKD | -100.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 FY | 2.35 Billion HKD | 16.17% |
| 2016 Q4 | 2.35 Billion HKD | 0.0% |
| 2016 Q2 | 2.16 Billion HKD | 0.0% |
| 2015 Q4 | 2.02 Billion HKD | 0.0% |
| 2015 Q2 | 1.87 Billion HKD | 0.0% |
| 2015 FY | 2.02 Billion HKD | 24.16% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 FY | 1.63 Billion HKD | 15.77% |
| 2014 Q4 | 1.63 Billion HKD | 0.0% |
| 2014 Q2 | 1.52 Billion HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2013 Q4 | 1.41 Billion HKD | 0.0% |
| 2013 Q2 | 1.25 Billion HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 1.41 Billion HKD | 110.82% |
| 2012 Q4 | 668.85 Million HKD | 0.0% |
| 2012 FY | 668.85 Million HKD | 39.51% |
| 2011 FY | 479.44 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| China Healthwise Holdings Limited | 149.67 Million HKD | -2862.815% |
| Tycoon Group Holdings Limited | 988.95 Million HKD | -348.399% |